Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Nicholas J Short, MD, Farhad Ravandi, MD, Alessandra Ferrajoli, MD, Heather M Schroeder, Maria Khouri, Guillermo Garcia-Manero, MD, Guillermo Montalban Bravo, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Marina Y. Konopleva, MD PhD, Koichi Takahashi, MD, Koji Sasaki, MD, Rebecca E. Garris, MSc, Elias J. Jabbour, MD

Blood (2018) 132 (Supplement 1): 32.

https://doi.org/10.1182/blood-2018-99-117470

Published: 2018

Journal Articles

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

Craig H. Moskowitz, MD, Andres Forero-Torres, MD, Bijal D. Shah, MD, Ranjana Advani, MD, Paul Hamlin, MD, Stella Kim, MD, Ana Kostic, MD, Larissa Sandalic, MS, Baiteng Zhao, PhD, Michelle A. Fanale, MD

Blood (2014) 124 (21): 1741.

https://doi.org/10.1182/blood.V124.21.1741.1741

Published: 2014

Journal Articles

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Uma Borate, MD, Amir T. Fathi, MD, Bijal D. Shah, MD, Daniel J. DeAngelo, MD, Ph.D, Lewis B. Silverman, MD, Todd Michael Cooper, Tina M. Albertson, MD, PhD, Megan M. O'Meara, MD, Larissa Sandalic, MS, Faith Stevison, MS, Robert Chen, MD

Blood (2013) 122 (21): 1437.

https://doi.org/10.1182/blood.V122.21.1437.1437

Published: 2013

Journal Articles

Side Population Cells of Human B-Cell Non-Hodgkin Lymphoma Cell Lines May Contain Lymphoma-Stem Cells Responsible for Lymphoma Initiation

Ha Yeon Lee, Mi Ran Lee, Won Seog Kim, Seok Jin Kim, MD, PhD

Blood (2010) 116 (21): 3105.

https://doi.org/10.1182/blood.V116.21.3105.3105

Published: 2010

Journal Articles

Genomic and Transcriptomic Analyses Revealed Differences and Similarities Between T-Lbl and T-ALL .

Lara Mussolin, Katia Basso, PhD, Antonella Lettieri, Manisha Brahmachary, PhD, Giovanni Cazzaniga, Andrea Califano, PhD, Wei-Keat Lim, Giuseppe Basso, Andrea Biondi, Angelo Rosolen

Blood (2009) 114 (22): 2943.

https://doi.org/10.1182/blood.V114.22.2943.2943

Published: 2009

NARROW

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Side Population Cells of Human B-Cell Non-Hodgkin Lymphoma Cell Lines May Contain Lymphoma-Stem Cells Responsible for Lymphoma Initiation

Genomic and Transcriptomic Analyses Revealed Differences and Similarities Between T-Lbl and T-ALL .

Email alerts

ASH Publications

American Society of Hematology

A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Non-Hodgkin Lymphoma

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Side Population Cells of Human B-Cell Non-Hodgkin Lymphoma Cell Lines May Contain Lymphoma-Stem Cells Responsible for Lymphoma Initiation

Genomic and Transcriptomic Analyses Revealed Differences and Similarities Between T-Lbl and T-ALL .

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only